Endothelin (ET) is a potent vasoconstrictor/ pressor peptide consisting of 21 amino acid residues isolated from the cultures of porcine aortic endothelial cells1}. Analysis of a human genomic library reveals three forms of ET (ET-1, ET-2 and ET-3) which have more than 70% homology with one another2). In various organs, high affinity and specific receptors for ET have been found3). They have been distinguished as receptors ETA and ETB4-5). ET-1 exhibits potent and long-lasting vasoconstrictive activity in vivo and in vitro1"1, as a result of binding to the ETAreceptor. In the course of our screening program for ET-1 binding inhibitors from microorganisms, we isolated asterric acid (Fig. 1, 1) as an active substance from the culture filtrate of a fungus, Aspergillus sp. Asterric acid had been reported as a metabolite of a fungus6'7). We have shown that it has the property of inhibiting ET-1 binding to the ETA receptor of A10 cells8).
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The fungus was cultivated on a rotary shaker at 25°C for 7 days in 500-ml Erlenmeyer flasks each containing 100ml ofKl5 medium which consists of 2% malt extract, 2% glucose, 0.1% peptone and 0.1% agar.
The filtrate of the fermentation broth (1 liter) was extracted twice with 500ml of ethyl acetate at pH 2. The organic layer was concentrated in vacuo and subjected to silica gel column chromatography A10 cells at 1 x 1O4cells/well were incubated with 125I-ET for 6 hours at 4°C. Various concentrations of asterric acid were coincubated during this periods. After incubation, cells were washed and cell-bound radioactivity was counted.
were examined. It showed no inhibitory activity against ANP and A II binding at 10~3m. These results indicate that asterric acid is a specific inhibitor of ET-1 binding.
Weprepared some derivatives ofasterric acid (Fig.  1) . The methylated compound (2) was obtained by using NaH-CH31. KOHtreatment gave demethyl asterric acid (3). The compound (4) was formed from (1) by treatment with chloroethyl formate, followed by hydrazine hydrate. These derivatives showed no ET-1 binding inhibitory activity at \0fiM. In particular, the activity of the demethyl form was less than 1%of that of asterric acid. Kojiri et al.9>10) and Miyata et al.lul2) have identified cyclic pentapeptides from an Actinomycete as ET binding inhibitors. As far as we know, asterric acid and WS00913)are the first non-peptide ET binding inhibitors to be identified. Asterric acid will be a useful tool to investigate the functions of ET.
